Co-Amlessa tablets

Χώρα: Αρμενία

Γλώσσα: Αγγλικά

Πηγή: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Δραστική ουσία:

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Διαθέσιμο από:

KRKA d.d.

Φαρμακολογική κατηγορία (ATC):

C09BX01

INN (Διεθνής Όνομα):

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Δοσολογία:

4mg+ 10mg+ 1,25mg

Φαρμακοτεχνική μορφή:

tablets

Μονάδες σε πακέτο:

(30/3x10/) in blister

Τρόπος διάθεσης:

Prescription

Καθεστώς αδειοδότησης:

Registered

Ημερομηνία της άδειας:

2016-07-20

Αρχείο Π.Χ.Π.

Summary of product characteristics
CONFIDENTIAL
Co-Amlessa tablet 2 mg/5 mg/0.625 mg, 4 mg/5 mg/1.25
mg, 4 mg/10 mg/1.25 mg, 8 mg/5 mg/2.5 mg, 8 mg/10
VOL: 1; P: 68 / 1048
1.3.1
Perindopril+Indapamide+Amlodipine
SPC, Labeling and Package Leaflet
AM
SmPCPIL153367_1
20.07.2020 – Updated: 20.07.2020
Page 1 of 27
1.
NAME OF THE MEDICINAL PRODUCT
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Each tablet
contains 2 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 0.625 mg
indapamide.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Each tablet contains 8 mg perindopril tert-butylamine, 5 mg amlodipine
(as besilate) and 2.5 mg
indapamide.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
Each tablet
contains 8 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 2.5 mg
indapamide.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Co-Amlessa 2 mg/5 mg/0.625 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The score line is only to facilitate breaking for ease of
swallowing and not to divide into equal
doses.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets: White to almost white, round,
slightly biconvex tablets with
bevel edges.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The tablet can be divided into equal doses.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets with bevel
edges.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets s